Pivotal Phase 3 SIERRA Trial Data Showing 100% Bone Marrow Transplant Engraftment in Patients Treated with Iomab-B presented at the 2021 Virtual SNMMI Conference prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Theralase Release FY2020 Audited Financial Statements newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
Theralase Release FY2020 Audited Financial Statements theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
Theralase Technologies Inc.: Theralase Releases Quarterly Newsletter
® Technologies Inc. (
TSXV:TLT)(
OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds (
PDC ) and associated drug formulations to safely and effectively destroy various cancers, bacteria and viruses has released the Company s Quarterly Newsletter (
Newsletter ) which provides updates on the previous quarter and progress on the Phase II Non-Muscle Invasive Bladder Cancer (
NMIBC ) Clinical Study (
Highlights from the Newsletter:
Clinical Study Sites ( CSS )
11 CSS s have been launched in Canada (5) and the US (6) for patient enrollment and treatment for Study II.
Patients Treated
Study II has enrolled and provided the primary study treatment for 18 patients (